SEC Comment Letter 0000000000-23-005704 to InspireMD, Inc. (NSPR)
InspireMD, Inc.
Date: May 30, 2023 · CIK: 0001433607 · Accession: 0000000000-23-005704
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-272149
Letter
United States securities and exchange commission logo May 30, 2023 Marvin Slosman Chief Executive Officer InspireMD, Inc. 4 Menorat Hamaor. St. Tel Aviv, Israel 6744832 Re:InspireMD, Inc. Registration Statement on Form S-3 Filed May 23, 2023 File No. 333-272149 Dear Marvin Slosman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Margaret Schwartz at 202-551-7153 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Gary Emmanuel, Esq.
Show Raw Text
United States securities and exchange commission logo
May 30, 2023
Marvin Slosman
Chief Executive Officer
InspireMD, Inc.
4 Menorat Hamaor. St.
Tel Aviv, Israel 6744832
Re:InspireMD, Inc.
Registration Statement on Form S-3
Filed May 23, 2023
File No. 333-272149
Dear Marvin Slosman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Margaret Schwartz at 202-551-7153 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Gary Emmanuel, Esq.